Head and Neck Cancer - Articles and news items

Head and neck cancer image

Head and neck cancer market fertile for investment

Industry news / 8 March 2017 / GBI Research

A substantial number of first-in-class products in the head and neck cancer pipeline will reach the market over the coming decade, which could potentially transform the clinical and commercial landscape, according to business intelligence firm GBI Research.

NICE says head and neck cancer drug cetuximab is not cost-effective

Industry news / 7 November 2016 / Niamh Louise Marriott, Digital Content Producer

NICE was reconsidering cetuximab as part of its programme to appraise drugs that are currently available on the Cancer Drugs Fund…

head and neck cancer

‘Game-changing’ immunotherapy doubles head and neck cancer survival

Industry news, Z Homepage promo / 10 October 2016 / Niamh Louise Marriott, Digital Content Producer

An immunotherapy drug has been hailed as a ‘game changer’ after being found to greatly improve survival for patients with relapsed head and neck cancer…

First patient recruited in Visco-ease RIX study

Industry news / 29 March 2016 / Victoria White

The study will assess Visco-ease’s ability to restore the function of saliva in patients undergoing radiotherapy for the treatment of Head and Neck Cancer…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...